Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;14(4):843-853.
doi: 10.1016/j.jcmg.2020.06.049. Epub 2021 Jan 13.

Basic Principles of the Echocardiographic Evaluation of Mitral Regurgitation

Affiliations
Free article
Review

Basic Principles of the Echocardiographic Evaluation of Mitral Regurgitation

Paul A Grayburn et al. JACC Cardiovasc Imaging. 2021 Apr.
Free article

Abstract

Mitral regurgitation (MR) is a common form of valvular heart disease that is associated with significant morbidity and mortality. Treatment decisions are completely dependent on accurate diagnosis of both mechanism and severity of MR, which can be challenging and is often done incorrectly. Transthoracic echocardiography is the most commonly used imaging test for MR; transesophageal echocardiography is often needed to better define morphology and MR severity, and is essential for guiding transcatheter therapies for MR. Multidetector computed tomography has become the standard to assess whether transcatheter valve replacement is an option because of its ability to assess valve sizing, access, and potential left ventricular outflow tract obstruction. Finally, cine cardiac magnetic resonance has been recommended by recent guidelines to quantify MR severity when the distinction between moderate and severe MR is indeterminate by echocardiography. This paper focuses on the main questions to be answered by imaging techniques and illustrates some common tips, tricks, and pitfalls in the assessment of MR.

Keywords: cardiac imaging; cine magnetic resonance; echocardiography; guidelines; mitral regurgitation.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr. Grayburn has been a consultant for Abbott Vascular, Edwards Lifesciences, Gore, Medtronic, and 4C Medical. Dr. Thomas has been a consultant for Abbott, Edwards Lifesciences, GE Healthcare, and Bay Labs.

MeSH terms

LinkOut - more resources